Oppenheimer Maintains Outperform on UnitedHealth Group, Raises Price Target to $500

Benzinga Newsdesk www.benzinga.com Positive 90.2%

Neg 0% Neu 0% Pos 90.2%

Oppenheimer analyst Michael Wiederhorn maintains UnitedHealth Group (NYSE:UNH) with a Outperform and raises the price target from $420 to $500.